Cargando…
Pseudoneutropenia in lymphangioleiomyomatosis (LAM) patients receiving sirolimus: evaluation in a 100 patient cohort
In lymphangioleiomyomatosis patients receiving sirolimus treatment, transient leukopenia in the morning may be due to circadian rhythm, with leukocyte counts recovering later in the day, indicating that a decrease in drug dose may not be warranted http://ow.ly/jPFz30iysgV
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862345/ https://www.ncbi.nlm.nih.gov/pubmed/29577040 http://dx.doi.org/10.1183/23120541.00121-2017 |
| _version_ | 1783308210478776320 |
|---|---|
| author | Gopalakrishnan, Vissagan Jones, Amanda M. Julien-Williams, Patricia Machado, Tania Danner, Robert L. Swigris, Jeffrey J. Paine, Robert Lozier, Jay N. Moss, Joel |
| author_facet | Gopalakrishnan, Vissagan Jones, Amanda M. Julien-Williams, Patricia Machado, Tania Danner, Robert L. Swigris, Jeffrey J. Paine, Robert Lozier, Jay N. Moss, Joel |
| author_sort | Gopalakrishnan, Vissagan |
| collection | PubMed |
| description | In lymphangioleiomyomatosis patients receiving sirolimus treatment, transient leukopenia in the morning may be due to circadian rhythm, with leukocyte counts recovering later in the day, indicating that a decrease in drug dose may not be warranted http://ow.ly/jPFz30iysgV |
| format | Online Article Text |
| id | pubmed-5862345 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | European Respiratory Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-58623452018-03-23 Pseudoneutropenia in lymphangioleiomyomatosis (LAM) patients receiving sirolimus: evaluation in a 100 patient cohort Gopalakrishnan, Vissagan Jones, Amanda M. Julien-Williams, Patricia Machado, Tania Danner, Robert L. Swigris, Jeffrey J. Paine, Robert Lozier, Jay N. Moss, Joel ERJ Open Res Original Research Letter In lymphangioleiomyomatosis patients receiving sirolimus treatment, transient leukopenia in the morning may be due to circadian rhythm, with leukocyte counts recovering later in the day, indicating that a decrease in drug dose may not be warranted http://ow.ly/jPFz30iysgV European Respiratory Society 2018-03-20 /pmc/articles/PMC5862345/ /pubmed/29577040 http://dx.doi.org/10.1183/23120541.00121-2017 Text en The content of this work is not subject to copyright. Design and branding are copyright ©ERS 2018 http://creativecommons.org/licenses/by-nc/4.0/ This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. |
| spellingShingle | Original Research Letter Gopalakrishnan, Vissagan Jones, Amanda M. Julien-Williams, Patricia Machado, Tania Danner, Robert L. Swigris, Jeffrey J. Paine, Robert Lozier, Jay N. Moss, Joel Pseudoneutropenia in lymphangioleiomyomatosis (LAM) patients receiving sirolimus: evaluation in a 100 patient cohort |
| title | Pseudoneutropenia in lymphangioleiomyomatosis (LAM) patients receiving sirolimus: evaluation in a 100 patient cohort |
| title_full | Pseudoneutropenia in lymphangioleiomyomatosis (LAM) patients receiving sirolimus: evaluation in a 100 patient cohort |
| title_fullStr | Pseudoneutropenia in lymphangioleiomyomatosis (LAM) patients receiving sirolimus: evaluation in a 100 patient cohort |
| title_full_unstemmed | Pseudoneutropenia in lymphangioleiomyomatosis (LAM) patients receiving sirolimus: evaluation in a 100 patient cohort |
| title_short | Pseudoneutropenia in lymphangioleiomyomatosis (LAM) patients receiving sirolimus: evaluation in a 100 patient cohort |
| title_sort | pseudoneutropenia in lymphangioleiomyomatosis (lam) patients receiving sirolimus: evaluation in a 100 patient cohort |
| topic | Original Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862345/ https://www.ncbi.nlm.nih.gov/pubmed/29577040 http://dx.doi.org/10.1183/23120541.00121-2017 |
| work_keys_str_mv | AT gopalakrishnanvissagan pseudoneutropeniainlymphangioleiomyomatosislampatientsreceivingsirolimusevaluationina100patientcohort AT jonesamandam pseudoneutropeniainlymphangioleiomyomatosislampatientsreceivingsirolimusevaluationina100patientcohort AT julienwilliamspatricia pseudoneutropeniainlymphangioleiomyomatosislampatientsreceivingsirolimusevaluationina100patientcohort AT machadotania pseudoneutropeniainlymphangioleiomyomatosislampatientsreceivingsirolimusevaluationina100patientcohort AT dannerrobertl pseudoneutropeniainlymphangioleiomyomatosislampatientsreceivingsirolimusevaluationina100patientcohort AT swigrisjeffreyj pseudoneutropeniainlymphangioleiomyomatosislampatientsreceivingsirolimusevaluationina100patientcohort AT painerobert pseudoneutropeniainlymphangioleiomyomatosislampatientsreceivingsirolimusevaluationina100patientcohort AT lozierjayn pseudoneutropeniainlymphangioleiomyomatosislampatientsreceivingsirolimusevaluationina100patientcohort AT mossjoel pseudoneutropeniainlymphangioleiomyomatosislampatientsreceivingsirolimusevaluationina100patientcohort |